Scolaris Content Display Scolaris Content Display

Comparison 1 Inhaled NO compared to control, Outcome 1 Death before discharge.
Figuras y tablas -
Analysis 1.1

Comparison 1 Inhaled NO compared to control, Outcome 1 Death before discharge.

Comparison 1 Inhaled NO compared to control, Outcome 2 Death before 36 weeks postmenstrual age.
Figuras y tablas -
Analysis 1.2

Comparison 1 Inhaled NO compared to control, Outcome 2 Death before 36 weeks postmenstrual age.

Comparison 1 Inhaled NO compared to control, Outcome 3 Bronchopulmonary dysplasia among survivors at 36 weeks.
Figuras y tablas -
Analysis 1.3

Comparison 1 Inhaled NO compared to control, Outcome 3 Bronchopulmonary dysplasia among survivors at 36 weeks.

Comparison 1 Inhaled NO compared to control, Outcome 4 Death or bronchopulmonary dysplasia at 36 weeks.
Figuras y tablas -
Analysis 1.4

Comparison 1 Inhaled NO compared to control, Outcome 4 Death or bronchopulmonary dysplasia at 36 weeks.

Comparison 1 Inhaled NO compared to control, Outcome 5 Intraventricular hemorrhage (all grades).
Figuras y tablas -
Analysis 1.5

Comparison 1 Inhaled NO compared to control, Outcome 5 Intraventricular hemorrhage (all grades).

Comparison 1 Inhaled NO compared to control, Outcome 6 Intraventricular hemorrhage (grade 3 or 4).
Figuras y tablas -
Analysis 1.6

Comparison 1 Inhaled NO compared to control, Outcome 6 Intraventricular hemorrhage (grade 3 or 4).

Comparison 1 Inhaled NO compared to control, Outcome 7 Intraventricular hemorrhage (grade 3 or 4) or periventricular leukomalacia.
Figuras y tablas -
Analysis 1.7

Comparison 1 Inhaled NO compared to control, Outcome 7 Intraventricular hemorrhage (grade 3 or 4) or periventricular leukomalacia.

Comparison 1 Inhaled NO compared to control, Outcome 8 Neurodevelopmental disability.
Figuras y tablas -
Analysis 1.8

Comparison 1 Inhaled NO compared to control, Outcome 8 Neurodevelopmental disability.

Comparison 1 Inhaled NO compared to control, Outcome 9 Cerebral Palsy.
Figuras y tablas -
Analysis 1.9

Comparison 1 Inhaled NO compared to control, Outcome 9 Cerebral Palsy.

Comparison 1 Inhaled NO compared to control, Outcome 10 Bayley MDI or PDI <‐2SD.
Figuras y tablas -
Analysis 1.10

Comparison 1 Inhaled NO compared to control, Outcome 10 Bayley MDI or PDI <‐2SD.

Comparison 1 Inhaled NO compared to control, Outcome 11 Severe retinopathy of prematurity (Stage 3 or more).
Figuras y tablas -
Analysis 1.11

Comparison 1 Inhaled NO compared to control, Outcome 11 Severe retinopathy of prematurity (Stage 3 or more).

Comparison 1 Inhaled NO compared to control, Outcome 12 Retinopathy of prematurity requiring surgery.
Figuras y tablas -
Analysis 1.12

Comparison 1 Inhaled NO compared to control, Outcome 12 Retinopathy of prematurity requiring surgery.

Comparison 1. Inhaled NO compared to control

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Death before discharge Show forest plot

14

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

1.1 Studies with entry before three days based on oxygenation

9

1006

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.90, 1.20]

1.2 Studies with entry after three days based on BPD risk

2

624

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.64, 1.74]

1.3 Studies of routine use in intubated preterm infants

3

1800

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.74, 1.11]

2 Death before 36 weeks postmenstrual age Show forest plot

7

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

2.1 Studies with entry before three days based on oxygenation

5

458

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.72, 1.11]

2.2 Studies with entry after three days based on BPD risk

1

42

Risk Ratio (M‐H, Fixed, 95% CI)

1.57 [0.74, 3.34]

2.3 Studies of routine use in preterm infants with lung disease

1

800

Risk Ratio (M‐H, Fixed, 95% CI)

1.34 [0.92, 1.95]

3 Bronchopulmonary dysplasia among survivors at 36 weeks Show forest plot

13

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

3.1 Studies with entry before three days based on oxygenation

8

681

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.76, 1.04]

3.2 Studies with entry after three days based on BPD risk

2

573

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.78, 1.02]

3.3 Studies of routine use in intubated preterm infants

3

1658

Risk Ratio (M‐H, Fixed, 95% CI)

0.94 [0.84, 1.05]

4 Death or bronchopulmonary dysplasia at 36 weeks Show forest plot

13

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

4.1 Studies with entry before three days based on oxygenation

8

958

Risk Ratio (M‐H, Fixed, 95% CI)

0.94 [0.87, 1.01]

4.2 Studies with entry after three days based on BPD risk

2

624

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.80, 1.02]

4.3 Studies of routine use in intubated preterm infants

3

1800

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.86, 1.01]

5 Intraventricular hemorrhage (all grades) Show forest plot

5

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

5.1 Studies with entry before three days based on oxygenation

3

254

Risk Ratio (M‐H, Fixed, 95% CI)

1.00 [0.73, 1.37]

5.2 Studies of routine use in preterm infants with respiratory disease

2

1573

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.88, 1.23]

6 Intraventricular hemorrhage (grade 3 or 4) Show forest plot

9

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

6.1 Studies with entry before three days based on oxygenation

6

773

Risk Ratio (M‐H, Fixed, 95% CI)

1.20 [0.98, 1.47]

6.2 Studies of routine use in intubated preterm infants

3

1789

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.74, 1.11]

7 Intraventricular hemorrhage (grade 3 or 4) or periventricular leukomalacia Show forest plot

11

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

7.1 Studies with entry before three days based on oxygenation

8

901

Risk Ratio (M‐H, Fixed, 95% CI)

1.08 [0.88, 1.33]

7.2 Studies of routine use in intubated preterm infants

3

1747

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.73, 1.12]

8 Neurodevelopmental disability Show forest plot

6

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

8.1 Studies with entry before three days based on oxygenation

2

208

Risk Ratio (M‐H, Fixed, 95% CI)

1.05 [0.78, 1.40]

8.2 Studies with entry after three days based on BPD risk

2

498

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.74, 1.09]

8.3 Studies of routine use in intubated preterm infants

2

593

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.72, 1.13]

9 Cerebral Palsy Show forest plot

6

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

9.1 Studies with entry before three days based on oxygenation

2

209

Risk Ratio (M‐H, Fixed, 95% CI)

1.85 [0.93, 3.71]

9.2 Studies with entry after three days based on BPD risk

2

498

Risk Ratio (M‐H, Fixed, 95% CI)

1.10 [0.54, 2.23]

9.3 Studies of routine use in intubated preterm infants

2

593

Risk Ratio (M‐H, Fixed, 95% CI)

0.94 [0.51, 1.70]

10 Bayley MDI or PDI <‐2SD Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

10.1 Studies of routine use in intubated preterm infants

1

138

Risk Ratio (M‐H, Fixed, 95% CI)

0.56 [0.33, 0.93]

11 Severe retinopathy of prematurity (Stage 3 or more) Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

11.1 Studies with entry before three days based on oxygenation

3

261

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.64, 1.47]

11.2 Studies of routine use in intubated preterm infants

1

207

Risk Ratio (M‐H, Fixed, 95% CI)

0.58 [0.22, 1.54]

12 Retinopathy of prematurity requiring surgery Show forest plot

6

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

12.1 Studies with entry before three days based on oxygenation

4

673

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.59, 1.29]

12.2 Studies with entry after three days based on BPD risk

1

582

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.78, 1.38]

12.3 Studies of routine use in intubated preterm infants

1

793

Risk Ratio (M‐H, Fixed, 95% CI)

1.09 [0.79, 1.50]

Figuras y tablas -
Comparison 1. Inhaled NO compared to control